These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15004434)

  • 41. Bradykinin metabolism in the postinfarcted rat heart: role of ACE and neutral endopeptidase 24.11.
    Raut R; Rouleau JL; Blais C; Gosselin H; Molinaro G; Sirois MG; Lepage Y; Crine P; Adam A
    Am J Physiol; 1999 May; 276(5):H1769-79. PubMed ID: 10330262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs.
    Thomas CV; McDaniel GM; Holzgrefe HH; Mukherjee R; Hird RB; Walker JD; Hebbar L; Powell JR; Spinale FG
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):902-12. PubMed ID: 9869495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of a dual inhibitor of angiotensin I-converting enzyme and neutral endopeptidase.
    French JF; Flynn GA; Giroux EL; Mehdi S; Anderson B; Beach DC; Koehl JR; Dage RC
    J Pharmacol Exp Ther; 1994 Jan; 268(1):180-6. PubMed ID: 8301555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemodynamic and humoral effects of vasopeptidase inhibition in canine hypertension.
    Maniu CV; Meyer DM; Redfield MM
    Hypertension; 2002 Oct; 40(4):528-34. PubMed ID: 12364358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of vasopeptidase inhibition on renal function and tubuloglomerular feedback in spontaneously hypertensive rats.
    Wang T; Takabatake T
    Hypertens Res; 2005 Jul; 28(7):611-8. PubMed ID: 16335890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Omapatrilat induces profound renal vasodilation but does not affect coronary hemodynamics.
    Varagic J; Susic D; Slama M; Frohlich ED
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):167-74. PubMed ID: 12808490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vasopeptidase inhibitors, neutral endopeptidase inhibitors, and dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Nawarskas J; Rajan V; Frishman WH
    Heart Dis; 2001; 3(6):378-85. PubMed ID: 11975822
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC; Robl JA; Asaad MM; Bird JE; Panchal BC; Schaeffer TR; Fox M; Giancarli MR; Cheung HS
    J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vasopeptidase inhibition with omapatrilat increases fluid and protein microvascular permeability in cat skeletal muscle.
    Persson J; Morsing P; Grände PO
    J Hypertens; 2004 Mar; 22(3):637-44. PubMed ID: 15076171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure.
    Xu J; Carretero OA; Liu YH; Yang F; Shesely EG; Oja-Tebbe N; Yang XP
    J Card Fail; 2004 Feb; 10(1):83-9. PubMed ID: 14966779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension.
    Quaschning T; d'Uscio LV; Shaw S; Lüscher TF
    Hypertension; 2001 Apr; 37(4):1108-13. PubMed ID: 11304511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice.
    Arnal JF; Castano C; Maupas E; Mugniot A; Darblade B; Gourdy P; Michel JB; Bayard F
    Atherosclerosis; 2001 Apr; 155(2):291-5. PubMed ID: 11254898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the effects of omapatrilat and irbesartan/hydrochlorothiazide on endothelial function and cardiac hypertrophy in the stroke-prone spontaneously hypertensive rat: sex differences.
    Graham D; Hamilton C; Beattie E; Spiers A; Dominiczak AF
    J Hypertens; 2004 Feb; 22(2):329-37. PubMed ID: 15076191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vasopeptidase Inhibition Corrects the Structure and Function of the Small Arteries in Experimental Renal Insufficiency.
    Haltia O; Törmänen S; Eräranta A; Jokihaara J; Nordhausen K; Rysä J; Ruskoaho H; Tikkanen I; Mustonen J; Pörsti I
    J Vasc Res; 2015; 52(2):94-102. PubMed ID: 26184548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fosinopril prevents the pulmonary arterial remodeling in sinoaortic-denervated rats by regulating phosphodiesterase.
    Tao X; Zhang YJ; Shen FM; Guan YF; Su DF
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):24-31. PubMed ID: 18209565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct inhibition of neutral endopeptidase in vasopeptidase inhibitor-mediated amelioration of cardiac remodeling in rats with chronic heart failure.
    Maki T; Nasa Y; Tanonaka K; Takahashi M; Takeo S
    Mol Cell Biochem; 2003 Dec; 254(1-2):265-73. PubMed ID: 14674706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic and renal effect of chronic omapatrilat in sodium-restricted, one-kidney, one-clip hypertensive rats.
    Jover B; Stuit L; Mimran A
    J Hypertens; 2004 Feb; 22(2):383-8. PubMed ID: 15076198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.